Related Experiment Video
Updated: Apr 18, 2026

Capturing Small Molecule Communication Between Tissues and Cells Using Imaging Mass Spectrometry
Published on: April 3, 2019
Serotonin and cancer: what is the link?
D Sarrouilhe, J Clarhaut, N Defamie
1Laboratoire de Physiologie Humaine, Faculte de Medecine et Pharmacie, 6 rue de La Miletrie, bat D1, TSA 51115, 86073 Poitiers Cedex 9, France. Denis.Sarrouilhe@univ-poitiers.fr.
Serotonin (5-hydroxytryptamine, 5-HT) influences cancer growth, with effects varying by concentration and receptor interaction. This review explores serotonin
Area of Science:
- Oncology
- Neuroscience
- Pharmacology
Background:
- Serotonin (5-hydroxytryptamine, 5-HT) is a key neurotransmitter and local mediator.
- It influences various physiological processes, including cell proliferation.
- Serotonin's role in cancer is complex and multifaceted.
Purpose of the Study:
- To re-evaluate the involvement of serotonin in various cancers.
- To analyze serotonin's role at different stages of cancer progression.
- To explore serotonin's impact on tumor growth, migration, and angiogenesis.
Main Methods:
- Literature review of studies on serotonin and cancer.
- Analysis of serotonin's interaction with 5-HT receptors (e.g., 5-HT1, 5-HT2).
- Examination of concentration-dependent effects of serotonin on tumor growth.
Main Results:
- Serotonin can stimulate tumor growth, particularly in aggressive cancers, via 5-HT1 and 5-HT2 receptors.
- Low doses of serotonin may inhibit tumor growth by reducing blood supply.
- Serotonin is implicated in cancer cell migration, metastasis, angiogenesis, and receptor expression dysregulation.
Conclusions:
- Serotonin's role in cancer is concentration-dependent and mediated by specific receptors.
- Serum serotonin levels may serve as a prognostic indicator for certain cancers.
- Targeting serotonin pathways (antagonists, inhibitors) shows potential for cancer treatment.
Related Concept Videos
Psychoneuroimmunology: Diabetes and Cancer
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The Tumor Microenvironment
Cancer
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
